These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36977151)

  • 1. Systemic Levels of Pro-Inflammatory Cytokines and Post-Treatment Modulation in Tuberculous Lymphadenitis.
    Kathamuthu GR; Moideen K; Sridhar R; Baskaran D; Babu S
    Trop Med Infect Dis; 2023 Feb; 8(3):. PubMed ID: 36977151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished circulating plasma and elevated lymph node culture supernatant levels of IL-10 family cytokines in tuberculous lymphadenitis.
    Kathamuthu GR; Kumar NP; Moideen K; Baskaran D; Hissar S; Shrinivasa BM; Sridhar R; Babu S
    Cytokine; 2018 Nov; 111():511-517. PubMed ID: 29871780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered plasma levels of βC and γC chain cytokines and post-treatment modulation in tuberculous lymphadenitis.
    Kathamuthu GR; Moideen K; Sridhar R; Baskaran D; Babu S
    Cytokine; 2021 Feb; 138():155405. PubMed ID: 33341600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitis.
    Kathamuthu GR; Moideen K; Banurekha VV; Nair D; Sridhar R; Baskaran D; Babu S
    PLoS One; 2018; 13(11):e0207404. PubMed ID: 30427928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma adipocytokines distinguish tuberculous lymphadenitis from pulmonary tuberculosis.
    Kathamuthu GR; Moideen K; Sridhar R; Baskaran D; Babu S
    Tuberculosis (Edinb); 2022 Jan; 132():102161. PubMed ID: 34891038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced neutrophil granular proteins and post-treatment modulation in tuberculous lymphadenitis.
    Kathamuthu GR; Moideen K; Sridhar R; Baskaran D; Babu S
    PLoS One; 2021; 16(6):e0253534. PubMed ID: 34153068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished systemic levels of antimicrobial peptides in tuberculous lymphadenitis and their reversal after anti-tuberculosis treatment.
    Kathamuthu GR; Moideen K; Sridhar R; Baskaran D; Subash Babu
    Tuberculosis (Edinb); 2020 May; 122():101934. PubMed ID: 32275232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helminth mediated modulation of the systemic and mycobacterial antigen - stimulated cytokine profiles in extra-pulmonary tuberculosis.
    Kathamuthu GR; Munisankar S; Sridhar R; Baskaran D; Babu S
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007265. PubMed ID: 30897083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced systemic and mycobacterial antigen-stimulated concentrations of IL-1β and IL-18 in tuberculous lymphadenitis.
    Kathamuthu GR; Moideen K; Bhaskaran D; Sekar G; Sridhar R; Vidyajayanthi B; Gajendraraj G; Babu S
    Cytokine; 2017 Feb; 90():66-72. PubMed ID: 27794266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered systemic levels of acute phase proteins in tuberculous lymphadenitis and modulation after treatment.
    Kathamuthu GR; Moideen K; Kumar NP; Sridhar R; Baskaran D; Babu S
    PLoS One; 2020; 15(5):e0233426. PubMed ID: 32470023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heightened systemic levels of anti-inflammatory cytokines in pulmonary tuberculosis and alterations following anti-tuberculosis treatment.
    Moideen K; Kumar NP; Bethunaickan R; Banurekha VV; Nair D; Babu S
    Cytokine; 2020 Mar; 127():154929. PubMed ID: 31811994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculous Lymphadenitis Is Associated with Enhanced Baseline and Antigen-Specific Induction of Type 1 and Type 17 Cytokines and Reduced Interleukin-1β (IL-1β) and IL-18 at the Site of Infection.
    Kathamuthu GR; Moideen K; Baskaran D; Banurekha VV; Nair D; Sekar G; Sridhar R; Vidyajayanthi B; Gajendraraj G; Parandhaman DK; Srinivasan A; Babu S
    Clin Vaccine Immunol; 2017 May; 24(5):. PubMed ID: 28249842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished type 1 and type 17 cytokine expressing - Natural killer cell frequencies in tuberculous lymphadenitis.
    Kathamuthu GR; Kumar NP; Moideen K; Sridhar R; Baskaran D; Babu S
    Tuberculosis (Edinb); 2019 Sep; 118():101856. PubMed ID: 31430696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low body mass index has minimal impact on plasma levels of cytokines and chemokines in tuberculous lymphadenitis.
    Kathamuthu GR; Sridhar R; Baskaran D; Babu S
    J Clin Tuberc Other Mycobact Dis; 2020 Aug; 20():100163. PubMed ID: 32420460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculous lymphadenitis is associated with altered levels of circulating angiogenic factors.
    Kathamuthu GR; Moideen K; Baskaran D; Sekar G; Rathinam S; Bharathi VJ; Ganeshan GR; Babu S
    Int J Tuberc Lung Dis; 2018 May; 22(5):557-566. PubMed ID: 29663962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered CD8(+) T cell frequency and function in tuberculous lymphadenitis.
    Kumar NP; Sridhar R; Hanna LE; Banurekha VV; Jawahar MS; Nutman TB; Babu S
    Tuberculosis (Edinb); 2014 Sep; 94(5):482-93. PubMed ID: 25027793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 dependent suppression of type 1, type 2 and type 17 cytokines in active pulmonary tuberculosis.
    Kumar NP; Gopinath V; Sridhar R; Hanna LE; Banurekha VV; Jawahar MS; Nutman TB; Babu S
    PLoS One; 2013; 8(3):e59572. PubMed ID: 23544075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of pro- and anti-inflammatory cytokines in active and latent tuberculosis by coexistent Strongyloides stercoralis infection.
    George PJ; Pavan Kumar N; Jaganathan J; Dolla C; Kumaran P; Nair D; Banurekha VV; Shen K; Nutman TB; Babu S
    Tuberculosis (Edinb); 2015 Dec; 95(6):822-828. PubMed ID: 26542223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses.
    Amelio P; Portevin D; Hella J; Reither K; Kamwela L; Lweno O; Tumbo A; Geoffrey L; Ohmiti K; Ding S; Pantaleo G; Daubenberger C; Perreau M
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541853
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Kathamuthu GR; Rajamanickam A; Sridhar R; Baskaran D; Babu S
    Front Immunol; 2022; 13():999614. PubMed ID: 36341407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.